BRIEF published on 06/02/2026 at 14:35, 19 hours 51 minutes ago Inventiva Resumes Trading on Euronext Paris Euronext Paris Debt Financing Trading Resumption Inventiva MASH Treatment
PRESS RELEASE published on 06/02/2026 at 14:30, 19 hours 56 minutes ago Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris Inventiva announces trading resumption of its ordinary shares on Euronext Paris following Debt Financing Transaction and ADS Offering Euronext Paris Ordinary Shares Clinical-Stage Biopharmaceutical Trading Resumption Inventiva
BRIEF published on 06/02/2026 at 07:35, 1 day 2 hours ago Temporary suspension of Inventiva shares on Euronext Paris Euronext Paris Funding Nasdaq Inventiva Temporary Suspension
BRIEF published on 06/02/2026 at 07:35, 1 day 2 hours ago Inventiva Halts Trading of Ordinary Shares on Euronext Paris Euronext Paris Trading Halt Inventiva MASH Treatment Nadsaq
PRESS RELEASE published on 06/02/2026 at 07:30, 1 day 2 hours ago Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris for a proposed financing transaction. Trading to resume after communication Euronext Paris Trading Halt Clinical Trial Inventiva Metabolic Dysfunction
BRIEF published on 05/26/2026 at 22:05, 7 days 12 hours ago Inventiva Announces its First Quarter 2026 Financial Results Financial Results Treasury Biopharmaceutical Inventiva NATiV3
PRESS RELEASE published on 05/26/2026 at 22:00, 7 days 12 hours ago Inventiva Reports 2026 First Quarter Financial Information¹ Inventiva reports first quarter 2026 financial information, with cash and cash equivalents at €75.0 million and short-term deposits at €121.5 million. Explore company's financial results and upcoming milestones Financial Information Inventiva NATiV3 Cash Equivalents Short-term Deposits
BRIEF published on 05/21/2026 at 22:05, 12 days 12 hours ago Inventiva at the 2026 Jefferies Global Healthcare Conference Biopharmaceutical Inventiva MASH Lanifibranor Jefferies Conference
BRIEF published on 05/21/2026 at 22:05, 12 days 12 hours ago Inventiva to Present at 2026 Jefferies Global Healthcare Conference Biopharmaceutical Inventiva Lanifibranor MASH Treatment Jefferies Conference
PRESS RELEASE published on 05/21/2026 at 22:00, 12 days 12 hours ago Inventiva to Present at 2026 Jefferies Global Healthcare Conference Inventiva to present at 2026 Jefferies Global Healthcare Conference in New York City. CEO Andrew Obenshain to speak on June 3, 2026, about MASH therapies Clinical-Stage Biopharmaceutical Inventiva Lanifibranor 2026 Jefferies Conference MASH Therapies
Published on 06/03/2026 at 10:00, 26 minutes ago Eagle Plains and Xcite Define Prospective Geophysical Trends at Beaver River Uranium Project, SK
Published on 06/03/2026 at 09:01, 1 hour 25 minutes ago Apex Announces Drill Program Expansion and H2 Exploration Plans at the Rift Rare Earth Project
Published on 06/03/2026 at 04:58, 5 hours 28 minutes ago Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026
Published on 06/03/2026 at 00:00, 10 hours 26 minutes ago Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
Published on 06/03/2026 at 10:15, 10 minutes ago Red Bull Basement Is Helping Founders Vibe Code Their Idea Into a Funded Startup Reality
Published on 06/03/2026 at 10:05, 20 minutes ago SLOVAKIAN BAR WINS INAUGURAL EUROPE'S 50 BEST BARS MICHTER'S ART OF HOSPITALITY AWARD
Published on 06/03/2026 at 10:00, 26 minutes ago World Bronchiectasis Conference 2026 returns to Hannover: 10 years of progress from neglected disease to global movement
Published on 06/03/2026 at 09:40, 45 minutes ago Medios AG: Contract of Executive Board Member Constantijn van Rietschoten extended ahead of schedule
Published on 06/03/2026 at 08:45, 1 hour 41 minutes ago Air Liquide announces milestone investment in South Korea to support SK hynix’s advanced AI memory chip project
Published on 06/02/2026 at 18:03, 16 hours 22 minutes ago Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 16 hours 44 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 16 hours 46 minutes ago Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million
Published on 06/02/2026 at 08:00, 1 day 2 hours ago EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
